Company
Arbutus Biopharma Corp (ABUS)
Standardized SEC financial data for Arbutus Biopharma Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001447028 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-271.0%
Net margin
-237.9%
Revenue growth (YoY)
128.2%
Return on equity
-43.8%
ROIC
-51.5%
Free cash flow
-$39.6M
Debt / equity
0.00×
Current ratio
15.73×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $6.9M | $11.0M | $39.0M | $18.1M | $6.2M | $14.1M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $123.3M | $191.0M | $184.3M | $132.3M | $122.6M | $91.5M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$51.4M | -$67.5M | -$35.4M | -$85.9M | -$64.8M | -$39.6M |
| Capital expenditures |
Get ABUS data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ABUS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ABUS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"